SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-010804
Filing Date
2018-02-16
Accepted
2018-02-16 16:02:39
Documents
2
Period of Report
2018-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1617
2 POA DOCUMENT poa.txt EX-24.3_769713 3680
  Complete submission text file 0001209191-18-010804.txt   6800
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address
Turner Heather D (Reporting) CIK: 0001403571 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30171 | Film No.: 18621168